Compounds > theophylline

theophylline and mrs 1754

theophylline has been researched along with mrs 1754 in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (60.00)	29.6817
2010's	3 (30.00)	24.3611
2020's	1 (10.00)	2.80

Authors

Authors	Studies
Jacobson, KA; Kim, HS; Kim, SA; Linden, J; Marshall, MA; Melman, N; Müller, CE	1
Chu, N; Gimbel, A; Hao, J; Kalla, R; Leung, K; Maa, T; Palle, V; Perry, T; Piscopio, A; Varkhedkar, V; Xiao, D; Zablocki, J; Zeng, D	1
Elzein, E; Gimbel, A; Kalla, RV; Li, X; Maa, T; Palle, V; Perry, T; Varkhedkar, V; Zablocki, J; Zeng, D	1
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J	1
Auchampach, JA; Gizewski, E; Kreckler, LM; Maas, GE; Maas, JE; Narayanan, J; van der Hoeven, D; Wan, TC	1
Bertarelli, DC; Borrmann, T; Florin, NC; Hinz, S; Li, W; Müller, CE; Scheiff, AB	1
Cheng, F; Liu, G; Tang, Y; Xu, Z	1
Azuaje, J; Carbajales, C; Crespo, A; El Maatougui, A; Escalante, L; García-Mera, X; González-Gómez, M; Gutiérrez-de-Terán, H; Miguez, G; Sotelo, E	1
Barawkar, DA; Basu, S; Bedse, G; Bonagiri, R; Chaturvedi, S; Chugh, A; Dusange, S; Ghosh, I; Goswami, A; Gundu, J; Jadhav, D; Karande, V; Kulkarni, A; Kumar, S; Menon, S; Mookhtiar, KA; Mukhopadhyay, P; Paliwal, S; Palle, VP; Panmand, A; Patel, M; Prasad, V; Quraishi, A; Ramdas, V; Reddy, BS; Rouduri, S; Thakre, R; Thorat, S; Waman, Y	1
Gaba, S; Gupta, GD; Monga, V; Patel, R; Saini, A; Singh, G	1

Reviews

1 review(s) available for theophylline and mrs 1754

Article	Year
Adenosine receptor antagonists: Recent advances and therapeutic perspective. European journal of medicinal chemistry, 2022, Jan-05, Volume: 227 Topics: Dose-Response Relationship, Drug; Humans; Molecular Structure; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Structure-Activity Relationship	2022

Other Studies

9 other study(ies) available for theophylline and mrs 1754

Article	Year
Structure-activity relationships at human and rat A2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions. Journal of medicinal chemistry, 2002, May-23, Volume: 45, Issue:11 Topics: Animals; Binding, Competitive; Cell Line; Cloning, Molecular; Humans; Ligands; Purinergic P1 Receptor Antagonists; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2B; Receptors, Purinergic P1; Recombinant Proteins; Structure-Activity Relationship; Xanthines	2002
The discovery of a selective, high affinity A(2B) adenosine receptor antagonist for the potential treatment of asthma. Bioorganic & medicinal chemistry letters, 2005, Feb-01, Volume: 15, Issue:3 Topics: Adenosine A2 Receptor Antagonists; Asthma; Drug Stability; Humans; Liver; Structure-Activity Relationship; Xanthines	2005
Novel 1,3-disubstituted 8-(1-benzyl-1H-pyrazol-4-yl) xanthines: high affinity and selective A2B adenosine receptor antagonists. Journal of medicinal chemistry, 2006, Jun-15, Volume: 49, Issue:12 Topics: Adenosine A2 Receptor Antagonists; Animals; Cell Line; Cricetinae; Cricetulus; Humans; Pyrazoles; Radioligand Assay; Theophylline; Xanthines	2006
Chemical genetics reveals a complex functional ground state of neural stem cells. Nature chemical biology, 2007, Volume: 3, Issue:5 Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells	2007
Characterization of the A2B adenosine receptor from mouse, rabbit, and dog. The Journal of pharmacology and experimental therapeutics, 2009, Volume: 329, Issue:1 Topics: Acetamides; Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Amino Acid Sequence; Animals; Brain Chemistry; Calcium; Cell Line; Cloning, Molecular; Cyclic AMP; DNA, Complementary; Dogs; Humans; Ligands; Mice; Molecular Sequence Data; Purines; Rabbits; Radioligand Assay; Receptor, Adenosine A2B; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Species Specificity	2009
1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: development and characterization of adenosine A2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specificity. Journal of medicinal chemistry, 2009, Jul-09, Volume: 52, Issue:13 Topics: Adenosine A2 Receptor Antagonists; Animals; Drug Design; Humans; Kinetics; Ligands; Mice; Protein Binding; Radioligand Assay; Rats; Receptor, Adenosine A2B; Xanthines	2009
Insights into binding modes of adenosine A(2B) antagonists with ligand-based and receptor-based methods. European journal of medicinal chemistry, 2010, Volume: 45, Issue:8 Topics: Adenosine A2 Receptor Antagonists; Amino Acid Sequence; Drug Discovery; Humans; Ligands; Models, Molecular; Molecular Conformation; Molecular Sequence Data; Protein Binding; Receptor, Adenosine A2B; Reproducibility of Results; Sequence Homology, Amino Acid	2010
Discovery of Potent and Highly Selective A2B Adenosine Receptor Antagonist Chemotypes. Journal of medicinal chemistry, 2016, Mar-10, Volume: 59, Issue:5 Topics: Adenosine A2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Discovery; Humans; Models, Molecular; Molecular Structure; Pyrimidinones; Receptor, Adenosine A2B; Structure-Activity Relationship	2016
A European journal of medicinal chemistry, 2017, Feb-15, Volume: 127 Topics: Adenosine A2 Receptor Antagonists; Animals; Brain; Chemistry Techniques, Synthetic; Drug Design; Male; Mice; Receptor, Adenosine A2B; Structure-Activity Relationship; Xanthine	2017